Literature DB >> 29807226

MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway.

Chunxiu Dai1, Yongyong Xie1, Xiaoping Zhuang2, Zhengzhong Yuan3.   

Abstract

BACKGROUND: MicroRNAs play important roles in the pathogenesis of various kinds of tumors. However, there are few studies on the expression profile and function of miRNAs in epithelial ovarian cancer. In this study, we performed microRNA array to compare the expression profile of microRNA in ovarian cancer tissues with noncancerous tissues.
METHODS: qRT-PCR was used to further confirm the microRNA expression levels in epithelial ovarian cancer tissues and cell lines. The function of microRNA was analyzed by overexpressing microRNA mimics followed by the analysis of cell cycle, proliferation, and metastasis. The downstream target of miR-206 was found and western blot analysis was performed to measure the activation of the downstream signaling pathway.
RESULTS: In this study, we found the expression of miR-206 was significantly down-regulated in epithelial ovarian cancer tissues and epithelial ovarian cancer cell lines. In epithelial ovarian cancer patients, downregulation of miR-206 was associated with metastasis and poor prognosis. In epithelial ovarian cancer cell lines, miR-206 contributed to the cell cycle regulation, cell apoptosis, and cancer cell metastasis. MiR-206 mimics inhibited cancer cell proliferation and metastasis, and induced cell apoptosis. Moreover, our results demonstrated that miR-206 directly targeted c-Met and repressed the activation of downstream AKT/mTOR signaling pathway.
CONCLUSION: Our results demonstrated that miR-206 was down-regulated in epithelial ovarian cancer tissues and cell lines. MiR-206 inhibits the development of epithelial ovarian cancer cell by directly targeting c-Met and inhibiting the c-Met/AKT/mTOR signaling pathway.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  AKT/mTOR; Epithelial ovarian cancer; MiR-206; MicroRNA profiling; c-Met

Mesh:

Substances:

Year:  2018        PMID: 29807226     DOI: 10.1016/j.biopha.2018.05.077

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  32 in total

1.  MiR-206 suppresses proliferation and epithelial-mesenchymal transition of renal cell carcinoma by inhibiting CDK6 expression.

Authors:  Zhen Guo; Haiyan Jia; Junke Ge
Journal:  Hum Cell       Date:  2020-04-10       Impact factor: 4.174

2.  Effects of photoelectric therapy on proliferation and apoptosis of scar cells by regulating the expression of microRNA-206 and its related mechanisms.

Authors:  Song Zhang; Zhen-Min Zhao; Hong-Yu Xue; Fang-Fei Nie
Journal:  Int Wound J       Date:  2019-12-18       Impact factor: 3.315

3.  MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.

Authors:  Ru-Jin Zhuang; Xiao-Xu Bai; Wei Liu
Journal:  Cancer Biol Ther       Date:  2019-03-12       Impact factor: 4.742

Review 4.  Current Update on Nanotechnology-Based Approaches in Ovarian Cancer Therapy.

Authors:  Boddapati Kalyani Bhardwaj; Sanu Thankachan; Priyanila Magesh; Thejaswini Venkatesh; Rie Tsutsumi; Padmanaban S Suresh
Journal:  Reprod Sci       Date:  2022-05-18       Impact factor: 3.060

Review 5.  A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview.

Authors:  Ahmad Saburi; Mohammad Saeed Kahrizi; Navid Naghsh; Hasti Etemadi; Ahmet İlhan; Ali Adili; Shadi Ghoreishizadeh; Rozita Tamjidifar; Morteza Akbari; Gülinnaz Ercan
Journal:  J Ovarian Res       Date:  2022-07-07       Impact factor: 5.506

6.  βKlotho, a direct target of miR-206, contributes to the growth of hepatoblastoma through augmenting PI3K/Akt/mTOR signaling.

Authors:  Tong Chen; Jianglong Chen; Xiuhao Zhao; Jing Zhou; Qingfeng Sheng; Linlin Zhu; Zhibao Lv
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

7.  Unravelling the Role of LncRNA WT1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in Lung Adenocarcinoma.

Authors:  Wen Li; Yu Liu; Zi Jin Li; Yi Shi; Jing Deng; Jie Bai; Liang Ma; Xiao Xi Zeng; Shan Shan Feng; Jia Li Ren; Fei Jun Luo; Duo Yan Rong; Xiao Qi Chen; Hua Qun Yin; Zhu Chen; Fu Da
Journal:  Biomolecules       Date:  2021-02-02

8.  Retracted Article: MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions.

Authors:  Qiang He; Haiyan Du; Yundong Li
Journal:  RSC Adv       Date:  2019-01-14       Impact factor: 3.361

9.  The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.

Authors:  Dan Fei; Guoqing Sui; Yang Lu; Long Tan; Zhao Dongxu; Kewei Zhang
Journal:  J Cell Mol Med       Date:  2018-12-19       Impact factor: 5.310

10.  FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression via NF-κB Signaling.

Authors:  Wenzhou Ding; Ye Fan; Wenbo Jia; Xiongxiong Pan; Guoyong Han; Yao Zhang; Zhiqiang Chen; Yiwei Lu; Jinyi Wang; Jindao Wu; Xuehao Wang
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.